Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

James M. BogenbergerDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Devora DelmanDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Nanna HansenDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Riccardo ValdezDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA

Veena FaubleDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Ruben A. MesaDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA

Raoul TibesDepartment of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USACorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

Information for

Open access

Opportunities

Help and information

Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature